Update on the COVID-19 pandemic

Information regarding COVID-19 is in constant change, as is the situation regarding vaccination and prioritization for immune-compromised individuals.

If you have any COVID-19-related questions, we’ve created a specific COVID section on our website that can be accessed by clicking here or by selecting the “News & Events” tab from our homepage. In this section, you’ll find the latest news and information about the pandemic in Canada from trustworthy and reliable sources.

Any specific questions that you may have regarding the COVID-19 vaccination, delays between vaccine dosing, and prioritization within your province are best answered by your healthcare team. They’re the ones who know you and your particular situation and are therefore in a position to best address your unique concerns.

Created by, and entirely focused on, Canadians impacted by myeloma, Myeloma Canada is the only national charitable organization committed to providing you with the most up-to-date and reliable information on myeloma. Some of the ways we do this is through our monthly e-newsletter, “Myeloma Matters”, as well as through our social media platforms.

Please don’t hesitate to contact us at contact@myeloma.ca or toll-free at 1-888-798-5771 with any questions regarding our programs and services.


Make a donation

Join the Community

Subscribe to our mailing list to receive our monthly newsletter as well as updates on a variety of topics about multiple myeloma such as access to new therapies and treatment options, advances in clinical trials, and more.

Complete the form to join our community

For patients and caregivers

Occasionally, we conduct patient and caregiver surveys to solicit input for submissions to the pan-Canadian Oncology Drug Review (pCODR) to support the provincial funding of new therapies. This is an important mechanism through which the voice of those most affected by drug approval decisions may share their experiences and opinions. Complete the form below to receive updates on our upcoming surveys.

Myeloma Canada ensures that the personal information you provide remains confidential. For more information, please refer to our privacy policy. You may unsubscribe from our newsletter at any time.